Activest Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.8K Sell
605
-254
-30% -$13.8K 0.01% 390
2026
Q1
$53.9K Sell
859
-309
-26% -$24.7K 0.01% 317
2025
Q4
$111K Buy
1,168
+762
+188% +$74.7K 0.02% 209
2025
Q3
$39.6K Buy
406
+49
+14% +$5.07K 0.01% 290
2025
Q2
$38.3K Sell
357
-22
-6% -$2.23K 0.01% 238
2025
Q1
$38.2K Buy
379
+373
+6,217% +$37.6K 0.01% 215
2024
Q4
$536 Buy
+6
New +$528 ﹤0.01% 524
2024
Q3
Sell
-116
Closed -$9.14K 581
2024
Q2
$8.93K Sell
116
-185
-61% -$13.5K ﹤0.01% 305
2024
Q1
$20.6K Hold
301
0.01% 173
2023
Q4
$17.4K Hold
301
0.01% 159
2023
Q3
$15.9K Sell
301
-738
-71% -$38.7K 0.01% 147
2023
Q2
$52.3K Buy
1,039
+738
+245% +$38.5K 0.04% 67
2023
Q1
$15K Buy
+301
New +$14.2K 0.01% 140
2022
Q3
Sell
-116
Closed -$4K 456
2022
Q2
$4K Hold
116
﹤0.01% 266
2022
Q1
$5K Buy
+116
New +$5.03K ﹤0.01% 253

Other funds holding BSX

Activest Wealth Management's BSX Position: Q2 2026 in Review

Activest Wealth Management reduced its Boston Scientific (BSX) stake by 30% in Q2 2026, selling an estimated $13.8K and leaving 605 shares worth $25.8K. The position accounts for 0.01% of the portfolio, ranked #390.

Activest Wealth Management first reported a position in BSX in Q1 2022 and has held it in 15 quarters since. The position peaked at $111K in Q4 2025. 424 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Activest Wealth Management held 605 shares of Boston Scientific worth $25.8K as of Q2 2026.
  • Activest Wealth Management sold 254 Boston Scientific shares in Q2 2026, an estimated $13.8K.
  • Boston Scientific made up 0.01% of Activest Wealth Management's portfolio in Q2 2026, its #390 holding.
  • Activest Wealth Management first reported a position in Boston Scientific in Q1 2022 and has held it in 15 quarters since.
  • Activest Wealth Management's Boston Scientific position peaked at $111K in Q4 2025.
  • 424 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.